packageBelinostat

belinostat

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Belinostat is a histone deacetylase inhibitor used as an anticancer medicine, mainly for treating peripheral T-cell lymphoma. It is an approved drug used in cancer care, though not authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q4882925 and the WHO ATC classification; not checked by a person.

name:belinostat
ATC codes:L01XH04
DrugBank:DB05015
PubChem CID:6918638
ChEBI:61076
Wikidata:Q4882925
formula:C15H14N2O4S
molar mass:318.347 g/mol (PubChem CID 6918638)
logP:1.7 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown